-+ 0.00%
-+ 0.00%
-+ 0.00%

Silence Therapeutics prices upsized $175 million ADS offering at $13.5 each

PUBT·08/12/2026 03:20:14
Listen to the news
Silence Therapeutics prices upsized $175 million ADS offering at $13.5 each
  • Silence Therapeutics priced an upsized underwritten public offering of 12,962,963 ADSs at USD 13.5 per ADS.
  • Gross proceeds expected to total about USD 175 million, before underwriting discounts, commissions, and offering expenses.
  • Underwriters received a 30-day option to buy up to 1,944,444 additional ADSs at the offering price.
  • Closing expected on or about Aug. 13, 2026, subject to customary closing conditions.
  • Jefferies, Morgan Stanley, Cantor, William Blair serving as joint book-running managers.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Silence Therapeutics plc published the original content used to generate this news brief via Business Wire (Ref. ID: 202608112320BIZWIRE_USPR_____20260811_BW003332) on August 12, 2026, and is solely responsible for the information contained therein.